Biocure Technology Inc.
CUREX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -346.70% | -385.29% | -0.27% | -18.52% | -34.97% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 255.78% | 260.74% | 170.98% | 992.96% | -20.64% |
| Change in Net Operating Assets | -55.37% | -58.93% | -51.88% | -50.33% | 136.81% |
| Cash from Operations | 115.91% | 112.49% | 105.66% | 74.89% | 45.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -80.05% | -43.59% | 86.17% |
| Cash from Investing | -100.00% | -100.00% | -80.05% | -43.59% | 3.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.93% | -100.77% | -102.71% | -70.30% | -35.38% |
| Cash from Financing | -115.46% | -112.64% | -116.93% | -78.80% | -46.30% |
| Foreign Exchange rate Adjustments | -100.00% | -100.00% | -100.00% | -- | 104.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.15% | 127.51% | 89.09% | 73.45% | 69.52% |